Literature DB >> 11787470

Inhibition of muscle glutamine formation in hypercatabolic patients.

G Biolo1, R Y Fleming, S P Maggi, T T Nguyen, D N Herndon, R R Wolfe.   

Abstract

Glutamine is synthesized primarily in skeletal muscle, and enables transfer of nitrogen to the liver, as well as serving other functions. There is increasing evidence for beneficial clinical effects of glutamine supplementation in critically ill patients. However, the response of endogenous glutamine formation to severe stress is poorly understood. The rates of net protein balance, leucine oxidative decarboxylation, and alanine and glutamine synthesis de novo were determined in leg skeletal muscle of 20 severely burned patients and 19 normal controls in the post-absorptive state. Patients were studied at 14+/-5 days post-burn, and their mean burn size was 66+/-18% of total body surface area. Methods were based on the leg arteriovenous balance technique in combination with biopsies of the vastus lateralis muscle. In the post-absorptive state, patients with severe burns, as compared with healthy control subjects, exhibited accelerated muscle loss (+150%) (i.e. proteolysis minus synthesis) and leucine oxidative decarboxylation (+117%), and depletion of the intramuscular free glutamine pool (-63%). The average rate of glutamine synthesis de novo was decreased by 48%, whereas net alanine synthesis de novo was increased by 174%, in skeletal muscle of burned patients. In conclusion, in severely hypercatabolic burned patients, muscle glutamine formation was suppressed, whereas alanine was the major vehicle for inter-organ nitrogen transport. These changes account for a decreased glutamine availability during prolonged severe stress.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11787470

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  12 in total

1.  Glutamine: a life-threatening deficiency in the critically ill?

Authors:  R D Griffiths; F Andrews
Journal:  Intensive Care Med       Date:  2001-01       Impact factor: 17.440

2.  Effect of intravenous amino acids on glutamine and protein kinetics in low-birth-weight preterm infants during the immediate neonatal period.

Authors:  Mark M Kadrofske; Prabhu S Parimi; Lourdes L Gruca; Satish C Kalhan
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-11-01       Impact factor: 4.310

3.  Physical inactivity decreases whole body glutamine turnover independently from changes in proteolysis.

Authors:  Francesco Agostini; Martina Heer; Gianfranco Guarnieri; Gianni Biolo
Journal:  J Physiol       Date:  2008-07-31       Impact factor: 5.182

4.  Glutamine deprivation causes enhanced plating efficiency of a herpes simplex virus type 1 ICP0-null mutant.

Authors:  Ryan M Bringhurst; Antonia A Dominguez; Priscilla A Schaffer
Journal:  J Virol       Date:  2008-09-03       Impact factor: 5.103

5.  Glutamine synthetase in muscle is required for glutamine production during fasting and extrahepatic ammonia detoxification.

Authors:  Youji He; Theodorus B M Hakvoort; S Eleonore Köhler; Jacqueline L M Vermeulen; D Rudi de Waart; Chiel de Theije; Gabrie A M ten Have; Hans M H van Eijk; Cindy Kunne; Wilhelmina T Labruyere; Sander M Houten; Milka Sokolovic; Jan M Ruijter; Nicolaas E P Deutz; Wouter H Lamers
Journal:  J Biol Chem       Date:  2010-01-11       Impact factor: 5.157

6.  Prevalence of glutamine deficiency in ICU patients: a cross-sectional analytical study.

Authors:  Arista Nienaber; Robin Claire Dolman; Averalda Eldorine van Graan; Renee Blaauw
Journal:  Nutr J       Date:  2016-08-02       Impact factor: 3.271

7.  Endogenous glutamine production in critically ill patients: the effect of exogenous glutamine supplementation.

Authors:  Maiko Mori; Olav Rooyackers; Marie Smedberg; Inga Tjäder; Ake Norberg; Jan Wernerman
Journal:  Crit Care       Date:  2014-04-14       Impact factor: 9.097

8.  Prolonged continuous intravenous infusion of the dipeptide L-alanine- L-glutamine significantly increases plasma glutamine and alanine without elevating brain glutamate in patients with severe traumatic brain injury.

Authors:  Mirjam Nägeli; Mario Fasshauer; Jutta Sommerfeld; Angela Fendel; Giovanna Brandi; John F Stover
Journal:  Crit Care       Date:  2014-07-02       Impact factor: 9.097

Review 9.  Glutamine: an obligatory parenteral nutrition substrate in critical care therapy.

Authors:  Peter Stehle; Katharina S Kuhn
Journal:  Biomed Res Int       Date:  2015-10-01       Impact factor: 3.411

10.  miR-424-5p reduces ribosomal RNA and protein synthesis in muscle wasting.

Authors:  Martin Connolly; Richard Paul; Roser Farre-Garros; Samantha A Natanek; Susannah Bloch; Jen Lee; Jose P Lorenzo; Harnish Patel; Cyrus Cooper; Avan A Sayer; Stephen J Wort; Mark Griffiths; Michael I Polkey; Paul R Kemp
Journal:  J Cachexia Sarcopenia Muscle       Date:  2017-12-07       Impact factor: 12.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.